Venturi Wealth Management LLC Decreases Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Venturi Wealth Management LLC has reduced its stake in UnitedHealth Group (NYSE:UNH) by 67.7%, leaving it with 11,990 shares valued at approximately $3.74 million.
• Despite the stake reduction by Venturi, other institutional investors like Vanguard Group and Wellington Management have increased their holdings in UnitedHealth Group, indicating continued interest in the stock.
• UnitedHealth reported earnings per share of $4.08 for the last quarter, missing analyst expectations, while its revenue increased by 12.9% compared to the previous year.

Venturi Wealth Management LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 67.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,990 shares of the healthcare conglomerate's stock after selling 25,156 shares during the quarter. Venturi Wealth Management LLC's holdings in UnitedHealth Group were worth $3,740,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. Bank of New York Mellon Corp increased its holdings in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after buying an additional 196,696 shares during the period. Nuveen LLC acquired a new position in UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after buying an additional 847,054 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.4%

Shares of NYSE:UNH opened at $363.95 on Wednesday. The business's 50 day moving average price is $311.44 and its 200-day moving average price is $352.42. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $329.62 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the company posted $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several research firms have commented on UNH. Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. KeyCorp lowered their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Robert W. Baird reiterated an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of "Hold" and a consensus target price of $365.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.